These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29933972)

  • 1. [Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?].
    de Moreuil C; Fauchais AL; Merviel P; Tremouilhac C; Le Moigne E; Pasquier E; Pan-Petesch B; Lacut K
    Rev Med Interne; 2018 Dec; 39(12):935-941. PubMed ID: 29933972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASPRE trial: performance of screening for preterm pre-eclampsia.
    Rolnik DL; Wright D; Poon LCY; Syngelaki A; O'Gorman N; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Papaioannou G; Tenenbaum-Gavish K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):492-495. PubMed ID: 28741785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.
    Poon LC; Wright D; Rolnik DL; Syngelaki A; Delgado JL; Tsokaki T; Leipold G; Akolekar R; Shearing S; De Stefani L; Jani JC; Plasencia W; Evangelinakis N; Gonzalez-Vanegas O; Persico N; Nicolaides KH
    Am J Obstet Gynecol; 2017 Nov; 217(5):585.e1-585.e5. PubMed ID: 28784417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocol.
    Mone F; Mulcahy C; McParland P; Stanton A; Culliton M; Downey P; McCormack D; Tully E; Dicker P; Breathnach F; Malone FD; McAuliffe FM
    Contemp Clin Trials; 2016 Jul; 49():143-8. PubMed ID: 27394381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm.
    Poon LC; Rolnik DL; Tan MY; Delgado JL; Tsokaki T; Akolekar R; Singh M; Andrade W; Efeturk T; Jani JC; Plasencia W; Papaioannou G; Blazquez AR; Carbone IF; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):738-742. PubMed ID: 29380918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
    Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
    BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is testing for aspirin response worthwhile in high-risk pregnancy?
    Rey E; Rivard GE
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):38-42. PubMed ID: 21440360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation.
    Yu CK; Papageorghiou AT; Parra M; Palma Dias R; Nicolaides KH;
    Ultrasound Obstet Gynecol; 2003 Sep; 22(3):233-9. PubMed ID: 12942493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of first trimester serum afamin levels and three-dimensional placental bed vascularization as a possible screening method to detect women at-risk for adverse pregnancy complications like pre-eclampsia and gestational diabetes mellitus in low-risk pregnancies.
    Tramontana A; Pablik E; Stangl G; Hartmann B; Dieplinger H; Hafner E
    Placenta; 2018 Feb; 62():9-15. PubMed ID: 29405972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE).
    O'Gorman N; Wright D; Rolnik DL; Nicolaides KH; Poon LC
    BMJ Open; 2016 Jun; 6(6):e011801. PubMed ID: 27354081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.
    Mendel A; Bernatsky SB; Hanly JG; Urowitz MB; Clarke AE; Romero-Diaz J; Gordon C; Bae SC; Wallace DJ; Merrill JT; Buyon JP; Isenberg DA; Rahman A; Ginzler EM; Petri M; Dooley MA; Fortin PR; Gladman DD; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Mackay M; Alarcón GS; Manzi S; Nived O; Jönsen A; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim S; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Sanchez-Guerrero J; Bruce IN; Costedoat-Chalumeau N; Vinet É
    Ann Rheum Dis; 2019 Jul; 78(7):1010-1012. PubMed ID: 30573656
    [No Abstract]   [Full Text] [Related]  

  • 13. External validation of a simple risk score based on the ASPRE trial algorithm for preterm pre-eclampsia considering maternal characteristics in nulliparous pregnant women: a multicentre retrospective cohort study.
    Brunelli E; Seidenari A; Germano C; Prefumo F; Cavoretto P; Di Martino D; Masturzo B; Morano D; Rizzo N; Farina A
    BJOG; 2020 Sep; 127(10):1210-1215. PubMed ID: 32275798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations.
    O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; de Alvarado M; Carbone IF; Dutemeyer V; Fiolna M; Frick A; Karagiotis N; Mastrodima S; de Paco Matallana C; Papaioannou G; Pazos A; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):756-760. PubMed ID: 28295782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
    Tan MY; Wright D; Syngelaki A; Akolekar R; Cicero S; Janga D; Singh M; Greco E; Wright A; Maclagan K; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):743-750. PubMed ID: 29536574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy.
    Parra-Cordero M; Rodrigo R; Barja P; Bosco C; Rencoret G; Sepúlveda-Martinez A; Quezada S
    Ultrasound Obstet Gynecol; 2013 May; 41(5):538-44. PubMed ID: 22807133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin.
    Navaratnam K; Abreu P; Clarke H; Jorgensen A; Alfirevic A; Alfirevic Z
    J Matern Fetal Neonatal Med; 2019 Jan; 32(2):179-187. PubMed ID: 28851242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
    Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
    BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
    Lancet; 1994 Mar; 343(8898):619-29. PubMed ID: 7906809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1998 update on pregnancy in lupus patients. New horizons, new hopes.
    Wechsler B; Du LT; Piette JC
    Rev Rhum Engl Ed; 1998 Nov; 65(11):619-24. PubMed ID: 9850529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.